Department of Pediatrics, Tohoku University Graduate School of Medicine, Sendai, Japan.
National Center for Child Health and Development, Tokyo, Japan.
Ann Neurol. 2019 Jun;85(6):927-933. doi: 10.1002/ana.25481. Epub 2019 Apr 25.
c-Jun-amino-terminal kinase-interacting protein 3 (JIP3), encoded by MAPK8IP3, is an adaptor protein of the kinesin-1 complex and essential for axonal transport in neurons. However, an association between MAPK8IP3 variants and human disease has not been established. We identified 5 individuals from four families with recurrent de novo variants c.1732C>T (p.Arg578Cys) and c.3436C>T (p.Arg1146Cys) in MAPK8IP3. The core phenotype includes spastic diplegia, intellectual disability, cerebral atrophy, and corpus callosum hypoplasia. Zebrafish embryos overexpressing human mutant JIP3 showed axon varicosities of the posterior lateral line nerve, suggesting an adverse effect on the developing axons. Our results suggest that MAPK8IP3 variants cause a neurodevelopmental disease. ANN NEUROL 2019;85:927-933.
c-Jun 氨基末端激酶相互作用蛋白 3(JIP3),由 MAPK8IP3 编码,是驱动蛋白-1 复合物的衔接蛋白,对神经元中的轴突运输至关重要。然而,MAPK8IP3 变体与人类疾病之间的关联尚未建立。我们在 MAPK8IP3 中鉴定了来自四个家族的 5 名个体,他们携带反复出现的新生变异 c.1732C>T(p.Arg578Cys)和 c.3436C>T(p.Arg1146Cys)。核心表型包括痉挛性双瘫、智力残疾、脑萎缩和胼胝体发育不良。过表达人突变 JIP3 的斑马鱼胚胎表现出后外侧线神经的轴突膨体,表明对发育中的轴突有不良影响。我们的研究结果表明,MAPK8IP3 变体导致神经发育疾病。神经病学年鉴 2019;85:927-933。